Immunic
IMUX
$1.53
Share price
1.83%
Change (1 day)
-30.51%
Change (1 year)
Categories
Immunic (IMUX) - Cash on Hand
Cash on Hand as of December 2024 : NZ$60.69 Million
According to Immunic's latest financial reports the company has NZ$60.69 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunic - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | NZ$73.8 M | -59.73% |
| 2022-12-31 | NZ$0.18 B | 44.13% |
| 2021-12-31 | NZ$0.12 B | -28.01% |
| 2020-12-31 | NZ$0.17 B | 305.06% |
| 2019-12-31 | NZ$43.6 M | 119.54% |
| 2018-12-31 | NZ$19.86 M | -75.21% |
| 2017-12-31 | NZ$80.11 M | -7.49% |
| 2016-12-31 | NZ$86.6 M | -28.94% |
| 2015-12-31 | NZ$0.12 B | -6.6% |
| 2014-12-31 | NZ$0.13 B | 180.81% |
| 2013-12-31 | NZ$46.46 M | 106.93% |
| 2012-12-31 | NZ$22.45 M | 2082.54% |
| 2011-12-31 | NZ$1.02 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | NZ$0.43 B | 617.62% | 🇺🇸 USA |